South Korea · Delayed Price · Currency is KRW NatureCell Statistics
Total Valuation
NatureCell has a market cap or net worth of KRW 1.54 trillion. The enterprise value is 1.54 trillion.
| Market Cap | 1.54T |
| Enterprise Value | 1.54T |
Important Dates
The next estimated earnings date is Wednesday, November 11, 2026.
| Earnings Date | Nov 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NatureCell has 64.44 million shares outstanding. The number of shares has increased by 0.18% in one year.
| Current Share Class | 64.44M |
| Shares Outstanding | 64.44M |
| Shares Change (YoY) | +0.18% |
| Shares Change (QoQ) | +0.10% |
| Owned by Insiders (%) | 2.07% |
| Owned by Institutions (%) | 5.34% |
| Float | 52.77M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 75.25 |
| PB Ratio | 24.52 |
| P/TBV Ratio | 25.44 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 75.17 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.76, with a Debt / Equity ratio of 0.31.
| Current Ratio | 1.76 |
| Quick Ratio | 1.36 |
| Debt / Equity | 0.31 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.88 |
| Interest Coverage | -7.13 |
Financial Efficiency
Return on equity (ROE) is -4.28% and return on invested capital (ROIC) is -6.35%.
| Return on Equity (ROE) | -4.28% |
| Return on Assets (ROA) | -2.86% |
| Return on Invested Capital (ROIC) | -6.35% |
| Return on Capital Employed (ROCE) | -5.58% |
| Weighted Average Cost of Capital (WACC) | 7.91% |
| Revenue Per Employee | 266.35M |
| Profits Per Employee | -35.19M |
| Employee Count | 87 |
| Asset Turnover | 0.26 |
| Inventory Turnover | 2.15 |
Taxes
In the past 12 months, NatureCell has paid 71.66 million in taxes.
| Income Tax | 71.66M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +14.05% in the last 52 weeks. The beta is 0.68, so NatureCell's price volatility has been lower than the market average.
| Beta (5Y) | 0.68 |
| 52-Week Price Change | +14.05% |
| 50-Day Moving Average | 23,681.00 |
| 200-Day Moving Average | 22,689.05 |
| Relative Strength Index (RSI) | 49.42 |
| Average Volume (20 Days) | 323,737 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NatureCell had revenue of KRW 20.51 billion and -2.71 billion in losses. Loss per share was -42.05.
| Revenue | 20.51B |
| Gross Profit | 10.07B |
| Operating Income | -3.68B |
| Pretax Income | -2.64B |
| Net Income | -2.71B |
| EBITDA | -1.72B |
| EBIT | -3.68B |
| Loss Per Share | -42.05 |
Balance Sheet
The company has 21.29 billion in cash and 19.78 billion in debt, with a net cash position of 1.51 billion or 23.46 per share.
| Cash & Cash Equivalents | 21.29B |
| Total Debt | 19.78B |
| Net Cash | 1.51B |
| Net Cash Per Share | 23.46 |
| Equity (Book Value) | 62.94B |
| Book Value Per Share | 976.87 |
| Working Capital | 17.27B |
Cash Flow
In the last 12 months, operating cash flow was -6.80 billion and capital expenditures -15.66 billion, giving a free cash flow of -22.46 billion.
| Operating Cash Flow | -6.80B |
| Capital Expenditures | -15.66B |
| Depreciation & Amortization | 1.95B |
| Net Borrowing | 16.02B |
| Free Cash Flow | -22.46B |
| FCF Per Share | -348.63 |
Margins
Gross margin is 49.10%, with operating and profit margins of -17.93% and -13.21%.
| Gross Margin | 49.10% |
| Operating Margin | -17.93% |
| Pretax Margin | -12.86% |
| Profit Margin | -13.21% |
| EBITDA Margin | -8.40% |
| EBIT Margin | -17.93% |
| FCF Margin | n/a |
Dividends & Yields
NatureCell does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.18% |
| Shareholder Yield | -0.18% |
| Earnings Yield | -0.18% |
| FCF Yield | -1.46% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NatureCell has an Altman Z-Score of 34.01 and a Piotroski F-Score of 1.
| Altman Z-Score | 34.01 |
| Piotroski F-Score | 1 |